---
schema_version: "secwatch.filing_event.v1"
accession: "0001493152-24-006885"
form_type: "8-K"
ticker: null
cik: "0001138978"
company_name: "Novo Integrated Sciences, Inc."
filed_at: "2024-02-15T23:59:59+00:00"
generated_at: "2026-06-06T00:46:07.483573+00:00"
event_type: "regulatory"
sentiment: "negative"
materiality_score: 0.7
calibrated_materiality_score: 0.7
confidence: "high"
source: SEC EDGAR
---

# Novo Integrated Sciences receives Nasdaq non-compliance notice for minimum bid price

## Summary
- Nasdaq notified NVOS on Feb 9, 2024 that it failed to maintain minimum bid of $1.00 per share for 30 consecutive business days.
- Non-compliance period: Dec 27, 2023 to Feb 8, 2024; stock continues trading on Nasdaq under symbol NVOS.
- Company has 180 days, until Aug 7, 2024, to regain compliance by closing at $1.00+ for 10 consecutive business days.
- If not cured by Aug 7, an additional 180 days may be granted if all other listing requirements are met.
- Failure to regain compliance could lead to delisting; company intends to monitor and consider available options.

## SEC filing metadata
- accession: 0001493152-24-006885
- form_type: 8-K
- cik: 0001138978
- company_name: Novo Integrated Sciences, Inc.
- filed_at: 2024-02-15T23:59:59+00:00
- event_type: regulatory
- sentiment: negative
- materiality_score: 0.7
- calibrated_materiality_score: 0.7
- confidence: high
- sec_items: 3.01, 9.01
- EDGAR index: https://www.sec.gov/Archives/edgar/data/1138978/000149315224006885/0001493152-24-006885-index.htm
- EDGAR primary document: https://www.sec.gov/Archives/edgar/data/1138978/000149315224006885/form8-k.htm

## Machine-readable alternates
- HTML: https://secwatch.observer/filing/0001493152-24-006885
- JSON: https://secwatch.observer/filing/0001493152-24-006885.json
- Plain text: https://secwatch.observer/filing/0001493152-24-006885.txt

## Key facts
- Listing & Compliance Notices
  Novo Integrated Sciences, Inc. received a nasdaq deficiency notice notice regarding minimum bid price (rules 5550(a)(2), 5810(c)(3)(A)).
  - Exchange: nasdaq
  - Notice: deficiency notice
  - Deficiency: minimum bid price
  - Rules: 5550(a)(2), 5810(c)(3)(A)
  source text: February 9, 2024, Novo Integrated Sciences, Inc., a Nevada corporation (the “Company”), received a notification letter (the “Notification Letter”) from The Nasdaq Stock Market, LLC (“Nasdaq”) that it is not in compliance with the minimum bid price requirements set forth in Nasdaq Listing Rule 5550(a)(2) for continued listing on The Nasdaq Capital Market. Nasdaq. Listing Rule 5550(a)(2) requires listed securities to maintain a minimum bid price of $1.00 per share, and Nasdaq Listing Rule 5810(c)(3)(A) provides that a failure to meet the minimum bid price requirement exists if the deficiency con
  evidence_url: https://www.sec.gov/Archives/edgar/data/1138978/000149315224006885/0001493152-24-006885-index.htm

This AI-assisted summary is a reading aid. Review the linked SEC EDGAR filing before relying on any specific claim.